Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue

Clinical Biochemistry

Volumn 34, Issue 7, 2001, Pages 557-562

  Chrzan, Pawel ^a   Skokowski, Jaroslaw ^a   Karmolinski, Andrzej ^a   Pawelczyk, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Breast cancer; c myc amplification; c Myc protein; Lymph node; Nonneoplastic tissue

Indexed keywords

MYC PROTEIN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER RISK; CANCER SIZE; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RISK FACTOR; WESTERN BLOTTING;

BREAST; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMANS; LYMPH NODES; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0035660705     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00260-0     Document Type: Article

References (36)

1. Myc target genes
2. The many roles of c-Myc in apoptosis
3. The molecular role of Myc in growth, and transformation: Recent discoveries lead to new insights
4. myc function, and regulation
5. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms, and normal development
6. Relationship of c-myc amplification to progresion of breast cancer from in situ to invasive tumor, and lymph node metastasis
7. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse
8. Influence of c-myc on the progression of human breast cancer
9. Synergistic cooperation between c-Myc, and Bcl-2 in lymph node progression of T1 human breast carcinomas
10. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer
11. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer
12. TP53, and MYC gene alterations independently predict poor prognosis in breast cancer patients
13. Steroid hormone receptor immunohistochemistry, and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer
14. Expression of the c-Myc protein in childhood medulloblastoma
15. Expression of c-myc, c-Ha- ras1, and c-erbB-2 proto-oncogenes in normal, and malignant human breast epithelial cells
16. c-myc, c-erbB2, and Ki-67 expression in normal breast tissue, and in invasive, and noninvasie breast carcinoma
17. Induction of differentiation, and growth arrest associated with nascent (nonoligosomal) DNA fragmentation, and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin
18. Expression of c-myc protein in breast cancer as related to established prognostic factors, and survival
19. Histological grading, and prognosis in breast cancer
20. Prognostic value of erb-B2, and myc amplification in breast cancer imprints
21. Protein measurements with the folin phenol reagent
22. Amplification of oncogenes in human cancer cells
23. Proto-oncogene amplification, and human breast tumour phenotype
24. c-Myc oncogene expression: A marker for females at risk of breast carcinoma
25. Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: Potential early indicators of treatment response
26. Apoptosis, and the cell cycle
27. Myc-mediated apoptosis
28. c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet
29. Molecular markers of carcinogenesis
30. Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin
31. Integrated control of cell proliferation, and apoptosis by oncogenes
32. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling
33. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation
34. Use of transgenic mice to study myc family gene function in normal mammalian development, and in cancer
35. Cooperation of TGFα and c-Myc in mouse mammary tumorigenesis: Coordinated stimulation of growth, and suppression of apoptosis
36. Differential regulation of cell cycle characteristics, and apoptosis in MMTV-myc, and MMTV-ras mouse mammary tumors